A new 20-year study of nearly 11,000 adults in Bangladesh found that lowering arsenic levels in drinking water was associated with up to a 50 percent lower risk of death from heart disease, cancer and other chronic illnesses, compared with continued exposure.Published today in the Journal of the American Medical Association, the study provides the first long-term, individual-level evidence that reducing arsenic exposure may lower mortality, even among people exposed to the toxic contaminant for years.
Metformin-associated lactic acidosis (MALA) is an uncommon but potentially life-threatening complication linked to the diabetes medication metformin. The condition occurs when excessive lactic acid builds up in the body, leading to dangerous changes in blood chemistry. Researchers developed and evaluated a clinical protocol aimed at improving how MALA is recognized and treated. Their findings were presented at ASN Kidney Week 2025.